ArticleHealth services research2011
The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?
Article in Health services research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed.
- The Effect of Financial Incentives on Quality Measures in the Treatment of Diabetes Mellitus: a Randomized Controlled Trial.Journal of general internal medicine · 2022Trial
- Trial
- Analyzing hospital behavior across different payment mechanism as a response to financial incentives - a scoping review.BMC health services research · 2026Article
- Diabetic Retinopathy Severity and Heart Failure Outcomes in Type 2 Diabetes Mellitus.Journal of diabetes · 2026Article
- Payment mechanism and medical quality: new evidence from China healthcare reform.BMC health services research · 2026Article
- Association of the Pay-for-Performance Program with Emergency Service Utilization and Hospital Admissions in Asthma Patients: A National Matched Cohort Study in Taiwan.Journal of medical systems · 2026Article
- The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting βAdvances in therapy · 2025Review
- Does asthma pay-for-performance program really improve the quality of asthma care: a nationwide retrospective cohort analysis in Taiwan.BMC pulmonary medicine · 2025Article
- Performance-based payment systems for general practitioners and specialists in selected countries: a comparative study.Journal of preventive medicine and hygiene · 2025Article
- Mandatory monthly outpatient visits could improve therapeutic inertia in patients with poorly controlled type 2 diabetes.Journal of diabetes investigation · 2024Article
- Diabetes Pay-for-Performance Program Participation and Dialysis Risk in Relation to Educational Attainment: A Retrospective Cohort Study.Healthcare (Basel, Switzerland) · 2023Article
- Participation and Outcomes among Disabled and Non-Disabled People in the Diabetes Pay-for-Performance Program.Healthcare (Basel, Switzerland) · 2023Article
- Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis.Cost effectiveness and resource allocation : C/E · 2023Article
- Assessing Taiwan's pay-for-performance program for diabetes care: a cost-benefit net value approach.The European journal of health economics : HEPAC : health economics in prevention and care · 2023Article
- The effect of a pay-for-performance program on health-related quality of life for patients with hepatitis in Taiwan.Health and quality of life outcomes · 2022Article
- Effect of blood pressure trajectory and variability on new-onset chronic kidney disease in patients with type 2 diabetes.Hypertension research : official journal of the Japanese Society of Hypertension · 2022Article
- Effect of socioeconomic status on survival in patients on the Diabetes Shared Care Program: Finding from a Taiwan nationwide cohort.Journal of the Chinese Medical Association : JCMA · 2022Article
- Lifetime risks of hip fracture in patients with type 2 diabetic: Taiwan Diabetes Study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021Article
- Chronic care model in the diabetes pay-for-performance program in Taiwan: Benefits, challenges and future directions.World journal of diabetes · 2021Review
- Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes.Journal of diabetes investigation · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTaiwan has instituted a pay-for-performance (P4P) program for diabetes mellitus (DM) patients that rewards doctors based in part on outcomes for their DM patients. Doctors are permitted to choose which of their DM patients are included in the P4P program. We test whether seriously ill DM patients are disproportionately excluded from the P4P program. DATA SOURCE/STUDY
settingThis study utilizes data from the National Health Insurance (NHI) database in Taiwan for the period of January 2007 to December 2007. Our sample includes 146,481 DM-P4P patients (16.56 percent of the total) and 737,971 non-DM-P4P patients. DATA COLLECTION/EXTRACTION
methodsWe use logistic and multilevel models to estimate the effects of patient and hospital characteristics on P4P selection. PRINCIPAL
findingsThe results show that older patients and patients with more comorbidities or more severe conditions are prone to be excluded from P4P programs.
conclusionsWe found that DM patients are disproportionately excluded from P4P programs. Our results point to the importance of mandated participation and risk adjustment measures in P4P programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.